Michael James Newman, CSO and Director at Indaptus Therapeutics, Inc. (INDP), sold 20,000 shares at $5.00 ($100K) on 2022-02-01, disclosed to the SEC on 2022-02-02.
Open-market sale of $100k INDP by CSO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 5,870 | $29K | 29.3% |
| 2 | $5.00 | 14,130 | $71K | 70.7% |
| Total | $5.00 avg | 20,000 | $100K | 100% |